| Product Name | MF | CAS | Details |
|---|
| 3-Aminorifamycin S | C37H46N2O12 | 51756-80-0 | Details |
| Palonosetron Hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| Ruxolitinib | C17H18N6 | 941678-49-5 | Details |
| Azilsartan Impurity I | C24H18N4O5 | 1403474-78-1 | Details |
| Azilsartan Impurity 52 | C27H25N3O6 | 139481-38-2 | Details |
| Azilsartan Impurity I | C23H17N3O3 | 139481-33-7 | Details |
| Azilsartan Impurity N | C22H17N3O4 | 2244031-86-3 | Details |
| Cabotegravir ；GSK744；GSK1265744 | C19H17F2N3O5 | 1051375-10-0 | Details |
| 4-iodo-3,5-diMethylbenzaMide | C9H10INO | 1206679-91-5 | Details |
| (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | C12H14ClN3O2 | 1146629-75-5 | Details |
| Folic Acid EP Impurity F | C7H6ClN5O | 1391194-56-1 | Details |
| 2-Acetamido-2-deoxy-b-D-thioglucopyranose | C8H15NO5S | 781581-10-0 | Details |
| Dimethyl (2E)-4-oxopent-2-enedioate | C7H8O5 | 78939-37-4 | Details |
| Rocuronium Bromide EP Impurity G | C27H46N2O3 | 119302-20-4 | Details |
| Aprepitant EP Impurity B | C29H25F7N4O3 | 2348441-62-1 | Details |
| Vitamin K1 impurity 2 | C20H40O2 | 107438-44-8 | Details |
| Dolutegravir Impurity 11 | C21H21F2N3O5 | 2227442-13-7 | Details |
| SB 204741 | C14H14N4OS | 152239-46-8 | Details |
| Azilsartan Impurity H | C23H20N4O4 | 1499167-72-4 | Details |
| Rifabutin N-Oxide | C46H62N4O12 | 645406-37-7 | Details |
| Methylprednisolone Hydrogen Succinate EP Impurity F | C26H34O8 | 2376134-25-5 | Details |
| N-((S)-10-formyl-5,6,7,8-tetrahydro-pteroyl)-L-glutamic acid | C20H23N7O7 | 74644-66-9 | Details |
| Treosulfan | C6H14O8S2 | 299-75-2 | Details |
| trans-Bilastine N-Oxide | C28H37N3O4 | 1934257-94-9 | Details |
| Azilsartan | C25H20N4O5 | 147403-03-0 | Details |
| N-((3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-5-oxotetrahydrofuran-3-yl)methyl)ethanesulfonamide | C16H18N6O4S | 2910813-43-1 | Details |
| Rocuronium bromide | C32H53BrN2O4 | 119302-91-9 | Details |
| Aprepitant EP Impurity A | C23H22F6N4O3 | 170729-76-7 | Details |
| Azilsartan Impurity C | C24H22N4O4 | 1397836-49-5 | Details |
| Azilsartan Impurity 45 | C22H19N3O2 | 136304-78-4 | Details |
| Dolutegravir Impurity 16 | C20H19F2N3O5 | 1357289-37-2 | Details |
| 16963392-11-6 | Details |
| (E)-4-(Dimethylamino)but-2-enoic acid | C6H11NO2 | 149586-32-3 | Details |
| Vecuronium Bromide EP Impurity D | C30H53BrN2O2 | 73319-30-9 | Details |
| 5,10-METHYLENETETRAHYDROFOLATE | C20H23N7O6 | 3432-99-3 | Details |
| Rocuronium Bromide EP Impurity C | C30H51BrN2O3 | 119302-86-2 | Details |
| Iguratimod Impurity | C16H19ClN2O5S | 149436-41-9 | Details |
| Azilsartan Impurity O | C23H19N3O4 | 2171316-29-1 | Details |
| Azilsartan Impurity K | C23H16N4O5 | 1442400-68-1 | Details |
| Rocuronium Bromide EP Impurity F | C34H55BrN2O4 | 1190105-66-8 | Details |
| 6-O-dodecanoyl-methyl-α-D-glucopyranoside | C19H36O7 | 20869-08-3 | Details |
| Salidroside | C14H20O7 | 10338-51-9 | Details |
| Vecuronium bromide | C34H57BrN2O4 | 50700-72-6 | Details |
| 9-α-D-Ribofuranosyl-9H-purin-6-amine | C10H13N5O4 | 5682-25-7 | Details |
| Aprepitant EP Impurity C | C29H25F7N4O3 | 2348441-63-2 | Details |
| Folic Acid EP Impurity H | C31H31N9O10 | 2366274-27-1 | Details |
| Ruxolitinib Impurity 17 | C18H21N5O2 | 2950130-23-9 | Details |
| Calcitriol EP Impurity A | C27H44O3 | 73837-24-8 | Details |
| 1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione | C13H9F4IN2O2 | 1150560-54-5 | Details |
| Impurity B of Calcitriol | C27H44O3 | 66791-71-7 | Details |
| Iguratimod Impurity | C16H16N2O6S | 149457-03-4 | Details |
| Ozanimod | C23H24N4O3 | 1306760-87-1 | Details |
| Dolutegravir Impurity 6 | C20H19F2N3O5 | 1357289-29-2 | Details |
| N-[1-(2,3-DIOLEYLOXY)PROPYL]-N,N,N-TRIMETHYLAMMONIUM CHLORIDE | C42H80ClNO4 | 132172-61-3 | Details |
| (R)-(4-(1-(2-cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | C23H28N6O2 | 1146629-80-2 | Details |
| 3,4-DI-O-ACETYL-6-DEOXY-L-GLUCAL | C10H14O5 | 34819-86-8 | Details |
| Vecuronium Bromide Impurity 4 | C31H52N2O3 | 13522-24-2 | Details |
| 2-AMINO-4-CHLORO-5H-PYRROLO[3,2-D]PYRIMIDINE | C6H5ClN4 | 943736-58-1 | Details |
| D-Folic Acid | C19H19N7O6 | 65165-91-5 | Details |
| Vitamin K1 impurity 3 | 127951-70-6 | Details |
| Thiamet G | C9H16N2O4S | 1009816-48-1 | Details |
| 11-cis,13-cis-Retinoic Acid | C20H28O2 | 3555-80-4 | Details |
| C35H49N3O5 | 86307-44-0 | Details |
| (3S)-N-[[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]Methyl]-1-azabicyclo[2.2.2]octan-3-aMine | C18H26N2 | 177793-80-5 | Details |
| Rocuronium Bromide EP Impurity B | C34H55BrN2O5 | 122483-73-2 | Details |
| Iguratimod Impurity | C18H16N2O6S | 123662-92-0 | Details |
| Azilsartan Impurity 3 | C29H25N3O7 | 1696392-12-7 | Details |
| Dolutegravir Impurity 3 | C20H19F2N3O5 | 1973402-05-9 | Details |
| Rocuronium Bromide EP Impurity A | C29H48N2O4 | 119302-24-8 | Details |
| Dolutegravir；GSK1349572 | C20H19F2N3O5 | 1051375-16-6 | Details |
| Rocuronium Bromide EP Impurity E | C32H53BrN2O3 | 1190105-65-7 | Details |
| Dolutegravir Impurity 9 | C20H20FN3O5 | 1863916-88-4 | Details |
| 2,16-Dipiperidin-1-ylandrosta-3,17-diol | C29H50N2O2 | 13522-16-2 | Details |
| Vitamin K1 impurity 1 | C20H38O | 220904-29-0 | Details |
| Imatinib mesylate | C30H35N7O4S | 220127-57-1 | Details |
| Primeverose | C11H20O10 | 26531-85-1 | Details |
| Baricitinib phosphate salt | C16H20N7O6PS | 1187595-84-1 | Details |
| Trans-Haloperidol N-Oxide | C21H23ClFNO3 | 150214-93-0 | Details |
| (R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide | C18H20ClN3O4S | 721401-53-2 | Details |
| Azilsartan Impurity M | C24H19N3O3 | 632322-61-3 | Details |
| Dolutegravir (S,R)-Isomer | C20H19F2N3O5 | 1309560-49-3 | Details |
| Iguratimod Impurity | C18H16N2O6S | 1179354-65-4 | Details |
| Dolutegravir Impurity 11 | C20H21N3O5 | 2244161-71-3 | Details |
| 4-OXO-ISOTRETINOIN | C20H26O3 | 71748-58-8 | Details |
| cis-Bilastine N-Oxide | C28H37N3O4 | 1934257-95-0 | Details |
| Ruxolitinib phosphate | C17H21N6O4P | 1092939-17-7 | Details |
| 3-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile | C17H26BN3O2 | 1153949-38-2 | Details |
| cis-Haloperidol N-Oxide | C21H23ClFNO3 | 150214-94-1 | Details |
| Rocuronium Bromide EP Impurity D | C32H53BrN2O4 | 1190105-63-5 | Details |
| Iguratimod Impurity | C16H14N2O5S | 123663-48-9 | Details |
| Azilsartan Impurity D | C22H18N4O4 | 1821386-21-3 | Details |
| Dolutegravir Impurity 8 | C20H19F2N3O5 | 2244161-72-4 | Details |
| 6-HYDROXYURIDINE | C9H12N2O7 | 19556-63-9 | Details |
| Elagolix Sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
| Azilsartan Impurity 37 | C25H23N3O4 | 147404-76-0 | Details |
| (2β,3α,5α,16β,17β)-2,16-Di-(1-piperidinyl)androstane-3,17-diol 3-Acetate | C31H52N2O3 | 53357-31-6 | Details |
| 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione | C20H15F5N2O3 | 1150560-59-0 | Details |
| Dolutegravir Impurity 10 | C20H20FN3O5 | 1863916-87-3 | Details |
| Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) | C21H26O3 | 69427-46-9 | Details |
| (2b,3a,16b,17b)-2,16-Bispiperidino-3,17-diacetoxy-5-androstane | C33H54N2O4 | 13529-31-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||